Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1T9YJ | ISIN: US12673W4078 | Ticker-Symbol:
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
CYTTA CORP Chart 1 Jahr
5-Tage-Chart
CYTTA CORP 5-Tage-Chart
ACCESS Newswire
399 Leser
Artikel bewerten:
(2)

Cytta Corp. Welcomes Florida Senator Jay Collins to Advisory Board, Bolstering Expertise in National Security and Technological Innovation

Finanznachrichten News

LAS VEGAS, NV / ACCESSWIRE / April 18, 2024 / Cytta Corp (OTCQB:CYCA), Today marks a significant enhancement in Cytta Corp.'s strategic direction as we proudly announce the appointment of Florida Senator Jay Collins to our Advisory Board. Senator Collins brings a wealth of experience from his illustrious career in public service and a deep commitment to advancing national security and technology.

With a distinguished military background spanning over two decades in the U.S. Army, where he completed several combat deployments and received numerous commendations, Senator Collins exemplifies leadership and dedication. His transition from military service to the Florida state legislature saw him champion initiatives that significantly benefited veterans, boosted small businesses, and reinforced the safety of American communities.

Senator Collins is a leading advocate for cutting-edge American technology, especially in the domains of cybersecurity and drone systems. His active support of the Blue UAS program underlines his vision for a secure technology infrastructure, ensuring that drones utilized by law enforcement and the military meet the highest standards of security and operational reliability.

Cytta Corp. is aligned with Senator Collins' advocacy for robust, American-made technology solutions. Our commitment is reflected in our advanced communication systems that cater to the specific needs of first responders and military operations, promoting both efficacy and safety.

Gary Campbell, CEO of Cytta Corp., expressed his enthusiasm about Senator Collins' board membership, stating, "Senator Collins' blend of patriotic service and strategic insight makes him an invaluable asset to our team. His foresight in national security matters and his alignment with our mission to innovate critical communication technologies will significantly enhance our contributions to public safety and technological advancements."

In his new role, Senator Collins will guide Cytta Corp. through the evolving landscape of cybersecurity and public safety technology. His legislative expertise and firsthand understanding of the challenges faced by first responders and military personnel are set to drive our strategic initiatives and broaden our impact.

About Cytta Corp:

Cytta Corp. is a leading technology solutions provider dedicated to delivering innovative products and services across various industries and revolutionizes the integration, streaming, transfer, and storage of video and audio data. With a focus on safety, security, and efficiency, Cytta Corp strives to develop cutting-edge solutions that address real-world challenges in large markets.
The Company's proprietary CyttaCOMMS incident management system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES , is a game-changer in ensuring the safety and well-being of children in educational institutions and beyond. CyttaAIR.com, a groundbreaking platform designed to innovate and consolidate the best of drone hardware, software, and resources for Federal and State Law Enforcement Agencies. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency, through their compression Licensee Reticulate Micro.

Contact Information:

Investor/Shareholder Contact:
Gary Zwetchkenbaum
PlumTree Consulting, LLC.
gzplumtree@gmail.com
Direct: (516)-455-7662

Cytta Corp.
Toll free #: 1 877 CYTTAUS (298 8287)
Call Local: 1 740 CYTTAUS (298 8287)
http://www.cytta.com
info@cytta.com

Gary Campbell, CEO
Direct (702) 900-7022 (or message)
Gary@cytta.com

Mike Elliott, VP of Business Development
mikeelliott@cytta.com
(689) 222-8708

SOURCE: Cytta Corp.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.